Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria

NCT ID: NCT03311347

Last Updated: 2019-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-14

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this project is to get further knowledge of the physiology of flight atelectasis and its prevention. We seek to: 1) assess whether low levels of positive pressure breathing can prevent atelectasis formation in humans during exposure to hyperoxia and +Gz-accelerations. 2) get further knowledge on the effects of hypobaria on regional ventilation and perfusion.

A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effect of positive pressure breathing on lung function is being studied, when applied during exposure to hyperoxia and +Gz-accelerations. Focus is on lung tissue compression, ventilation and regional perfusion. In addition, the influence of hypobaria on these parameters is assessed.

This study is conducted in accordance with the amended Declaration of Helsinki. The Ethics Committee Ile-de-France III (ref. 3274) and the French National Agency for Drug Safety ANSM have approved the protocol (ref. ID RCB 2015-A00485-44 and ANSM 151046B-32).

Primary aim, item 1: Experiments are conducted in a human centrifuge. The protocol mimics a routine peacetime flight in combat aircraft, and includes 1hr05 min at +1Gz followed by 10-min exposure to +1.4 to +3.5Gz . Subjects are exposed three times to this sequence, breathing at positive pressure levels of 0, 5 or 10 hPa. Two groups of sixteen healthy male non-smoking volunteers, wearing anti-G trousers, are studied and compared: group 1 breathes air, group 2 100% O2.

Primary aim, item 2: Experiments are conducted in a hypobaric chamber. Sixteen healthy male non-smoking volunteers are exposed to four conditions: 0 or 15,000 ft altitude, breathing air or 100%O2. Protocol duration is 1h15min. Positive breathing pressure can be applied depending on the results of the experiments of item 1.

Secondary aim: Experiments are conducted in a human centrifuge. Sixteen healthy male non-smoking volunteers are exposed to four conditions: uninflated or inflated anti-G trousers (175 hPa), +1 or +3.5 Gz for 3 min.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Atelectasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Two arms are studied, breathing air or 100%O2. In each arm, subjects are studied at two occasions: with and without positive pressure breathing. These occasions are randomized.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

100%O2 breathing

Primary aim, item 1

Group Type EXPERIMENTAL

+Gz accelerations and positive pressure breathing

Intervention Type OTHER

Air breathing

Primary aim, item 1

Group Type EXPERIMENTAL

+Gz accelerations and positive pressure breathing

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

+Gz accelerations and positive pressure breathing

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* normal lung function checked by pulmonary function tests.
* normal ECG
* normal clinical examination

Exclusion Criteria

* smoking
* myopia
* past medical history of heart or lung disease
* current medical treatment for heart or lung disease
* past medical history of back pain or spine trauma or disease
* otitis
* bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)
* claustrophobia in the centrifuge gondola


* smoking
* past medical history of heart or lung disease
* current medical treatment for heart or lung disease
* otitis
* bad tolerance to the altitude chamber (15,000 ft): ear pain, claustrophobia
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uppsala University Hospital

OTHER

Sponsor Role collaborator

Percy Hospital

UNKNOWN

Sponsor Role collaborator

Direction Centrale du Service de Santé des Armées

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominique Felten, MD

Role: STUDY_CHAIR

Armed Forces Biomedical Research Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Armed Forces Biomedical Research Institute

Brétigny-sur-Orge, , France

Site Status RECRUITING

Department of Radiology, Percy hospital

Clamart, , France

Site Status ACTIVE_NOT_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stephanie S Montmerle-Borgdorff, MD, PhD

Role: CONTACT

+33(1)78651249

Catherine Verret, MD, PhD

Role: CONTACT

+33(1)78651115

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stephanie S Montmerle-Borgdorff, MD, PhD

Role: primary

+33(1)78651249

Maquilon-Lefebvre David, nurse

Role: backup

+33(1)78651091

References

Explore related publications, articles, or registry entries linked to this study.

Dussault C, Gontier E, Verret C, Soret M, Boussuges A, Hedenstierna G, Montmerle-Borgdorff S. Hyperoxia and hypergravity are independent risk factors of atelectasis in healthy sitting humans: a pulmonary ultrasound and SPECT/CT study. J Appl Physiol (1985). 2016 Jul 1;121(1):66-77. doi: 10.1152/japplphysiol.00085.2016. Epub 2016 Apr 21.

Reference Type BACKGROUND
PMID: 27103651 (View on PubMed)

Borges JB, Hedenstierna G, Bergman JS, Amato MB, Avenel J, Montmerle-Borgdorff S. First-time imaging of effects of inspired oxygen concentration on regional lung volumes and breathing pattern during hypergravity. Eur J Appl Physiol. 2015 Feb;115(2):353-63. doi: 10.1007/s00421-014-3020-9. Epub 2014 Oct 17.

Reference Type RESULT
PMID: 25323531 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PDH1-SMO2-0714

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.